Talis Biomedical logo

Talis BiomedicalNASDAQ: TLIS

Profile

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

12 February 2021

Website:

http://talisbio.com

Next earnings report:

09 August 2024

Last dividends:

N/A

Next dividends:

N/A

Market cap

$15.70 M
-95%vs. 3y high
21%vs. sector

PE ratio

-
-vs. 3y high
-vs. sector

PB ratio

0.28
-74%vs. 3y high
21%vs. sector

PS ratio

45.11
-7%vs. 3y high
90%vs. sector

Price

regular market | Thu, 27 Jun 2024 13:30:00 GMT
$8.62+$0.12(+1.35%)

Dividend

No data over the past 3 years

EPS diluted

EPS diluted target

-$7.15-

Revenue

Revenue target

$73.00 K-

Revenue

Net income

$73.00 K-$13.04 M

Analysts recommendations

Total assets

Total liabilities

$82.49 M$25.81 M

Institutional Ownership

Included in screeners

Small cap companies
Stocks with high beta
Analysts recommendation: sell
Growing shares outstanding

Similar companies

Talphera logo

Talphera (TLPH)

Unicycive Therapeutics logo

Unicycive Therapeutics (UNCY)

Evaxion Biotech A/S logo

Evaxion Biotech A/S (EVAX)

Lyra Therapeutics logo

Lyra Therapeutics (LYRA)

QT Imaging Holdings logo

QT Imaging Holdings (QTI)

Alterity Therapeutics Limited logo

Alterity Therapeutics Limited (ATHE)

Aspira Womens Health logo

Aspira Womens Health (AWH)

Microbot Medical logo

Microbot Medical (MBOT)

TLIS Latest News

Talis Biomedical Corporation (TLIS) Q1 2023 Earnings Call Transcript
Seeking Alpha14 May 2023 Sentiment: POSITIVE

Talis Biomedical Corporation (NASDAQ:TLIS ) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ET Company Participants Emily Faucette - Senior Vice President, Corporate Communications & Investor Relations Rob Kelley - Chief Executive Officer Becky Markovich - Interim Chief Financial Officer Conference Call Participants Mark Massaro - BTIG Operator Good day and thank you for standing by. Welcome to the Talis Biomedical's Business Update Conference Call.

What type of business is Talis Biomedical?

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.

What sector is Talis Biomedical in?

Talis Biomedical is in the Healthcare sector

What industry is Talis Biomedical in?

Talis Biomedical is in the Medical Devices industry

What country is Talis Biomedical from?

Talis Biomedical is headquartered in United States

When did Talis Biomedical go public?

Talis Biomedical initial public offering (IPO) was on 12 February 2021

What is Talis Biomedical website?

https://talisbio.com

Is Talis Biomedical in the S&P 500?

No, Talis Biomedical is not included in the S&P 500 index

Is Talis Biomedical in the NASDAQ 100?

No, Talis Biomedical is not included in the NASDAQ 100 index

Is Talis Biomedical in the Dow Jones?

No, Talis Biomedical is not included in the Dow Jones index

When does Talis Biomedical report earnings?

The next expected earnings date for Talis Biomedical is 09 August 2024